SJ

Suthagar Jeyasoorian

Active Director Director DIN 10483709
DIN 10483709 First appointment Jan 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Suthagar Jeyasoorian

Data last updated:

Suthagar Jeyasoorian is a Director at Aj Multispeciality Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 10483709
Primary Designation Director
Industry Healthcare
First Appointment 30 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20242024Active

Directorship timeline

Open interactive timeline →
Aj Multispeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Suthagar Jeyasoorian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suthagar Jeyasoorian

Suthagar Jeyasoorian currently holds 1 directorship: Aj Multispeciality Hospital Private Limited (Director, since 30 Jan 2024).

Suthagar Jeyasoorian was first appointed on 30 Jan 2024 as Director at Aj Multispeciality Hospital Private Limited.

The current boards of Suthagar Jeyasoorian's companies include Bsuthagar (Aj Multispeciality Hospital Private Limited), Murugasamy Chandrakala (Aj Multispeciality Hospital Private Limited), Puvitha Subbiah (Aj Multispeciality Hospital Private Limited), Velusamy Ashwin Kumar (Aj Multispeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available